Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
已完结
10
由 sz 发布于 2025/10/9 9:02:10
DOI:10.1038/s41591-024-03003-9
作者：Xiaohua Wu,?Jihong Liu,?Jing Wang,?Li Wang,?Zhongqiu Lin,?Xiaobin Wang,?Jianqing Zhu,?Beihua Kong,?Junwei Fei,?Ying Tang,?Bairong Xia,?Zhiqing Liang,?Ke Wang,?Yi Huang,?Hong Zheng,?An Lin,?Kui Jiang,?
文献类型：期刊论文
补充材料：只需要正文
作者：Xiaohua Wu,?Jihong Liu,?Jing Wang,?Li Wang,?Zhongqiu Lin,?Xiaobin Wang,?Jianqing Zhu,?Beihua Kong,?Junwei Fei,?Ying Tang,?Bairong Xia,?Zhiqing Liang,?Ke Wang,?Yi Huang,?Hong Zheng,?An Lin,?Kui Jiang,?
文献类型：期刊论文
补充材料：只需要正文
Nature
其它数据库
Elsevier
京公网安备 11010802042870号
